Low-dose tirofiban is associated with reduced in-hospital mortality in cardioembolic stroke patients treated with endovascular thrombectomy
Wenbo Zhao(Capital Medical University), Xunming Ji(Capital Medical University), Sijie Li(Tsinghua–Berkeley Shenzhen Institute), Longfei Wu(Capital Medical University), Ruixian Wang(Tianjin Beichen Hospital), Guiyou Liu(Capital Medical University), Chuanjie Wu(Capital Medical University), Qingfeng Ma(Capital Medical University), Haiqing Song(Capital Medical University), Jian Chen(Army Medical University), Chuanhui Li(Guizhou University), Changhong Ren(Capital Medical University), Jiangang Duan(Capital Medical University), Jiali Xu
Cited by 12
Related Papers
Stroke in China: advances and challenges in epidemiology, prevention, and management
|The Lancet Neurology|2019|1.6k
Transfer of mitochondria from astrocytes to neurons after stroke
|Nature|2016|1.4k
Temporal trend and attributable risk factors of stroke burden in China, 1990–2019: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2021|899
Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion
|New England Journal of Medicine|2022|707
Tailoring Rod‐Like FeSe<sub>2</sub> Coated with Nitrogen‐Doped Carbon for High‐Performance Sodium Storage
|Advanced Functional Materials|2018|371